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duced more MMP-1 or MMP-1 after IL-I~ or TNF-~ stimulation 
as compared to the hip chondrocytes that were derived from the 
same animal. 
Conclusions: MMP-1 and MMP-13 have been implicated in type 
II collagen degradation in cartilage. We have shown for the first 
time that MMP-1 and MMP-13 production differs in knee and hip 
cartilage at different ages in porcine chondrocytes. Chondrocytes 
from newborn pigs produced the most collagenases after I L-1 ~ or 
TNF-~ stimulation. This may be due to high rate of ECM turnover 
needed for skeletal growth, as oppose to young adult pigs. Inter- 
estingly, this responsiveness reoccurs in the chondrocytes from 
old adult pigs and may result in ECM remodeling in joints of older 
individuals. Further study into the signaling of IL-I~ and TNF-~ 
on MMP-1 and MMP-13 production in aging knee and hip carti- 
lage could provide different pathways in collagenase synthesis in 
aging joints. 
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This study assessed ADAMTS "aggrecanase" expression and ac- 
tivity in murine neonatal epiphyseal chondrocytes, maintained as 
non-adherent aggregates in vitro. 
Distal femoral and proximal humeral epiphyses were collected 
from 4-day-old mice. Chondrocytes were isolated by collagenase 
digestion and cultured as non-adherent aggregates in serum-free 
medium supplemented with ascorbic acid. Cultures were main- 
tained for up to 12 days, with sample collections at 3-day in- 
tervals. GAG content in the pericellular and medium compart- 
ments was monitored by DMMB assays. Aggrecan expression 
and degradation were assessed by Western blot analyses of 
chondroitinase-treated lysates, using antibodies specific for the 
full-length protein and neoepitopes created by ADAMTS activ- 
ity. Expression of cartilage-linked ADAMTS genes (TSs 1, 4, 5, 
8, 9 and 15) was determined by RT-PCR. Immunolocalization of
ADAMTS 4 and 5, the NITEGE neo-epitope and hyaluronan was 
carried out using confocal microscopy to determine the spatial in- 
teractions between these targets in the three-dimensional context 
of the aggregates. 
Murine epiphyseal chondrocytes ynthesized 60-80 I~g GAG/mil- 
lion cells/3-days. Approximately 10% of total GAG was retained 
in the pericellular compartment while 90% was released into the 
medium. Aggrecan immunoblotting demonstrated spontaneous 
degradation of the full-length protein with neoepitope xpression 
characteristic of ADAMTS activity. Epiphyseal chondrocytes ex- 
pressed all six of the cartilage-linked ADAMTSs, as assessed by 
RT-PCR. Confocal immunolocalization f ADAMTS 4 and 5 in the 
aggregates demonstrated that ADAMTS4 is restricted to the sur- 
face cells only, whereas -TS5 is distributed throughout the aggre- 
gates. These data suggest that ADAMTS expression is influenced 
by spatial or intercellular cues. Further, the NITEGE neo-epitope, 
that signifies ADAMTS cleavage of the aggrecan core protein, 
was excluded from regions that stained positively for hyaluronan. 
Hyaluronan interactions with the aggrecan complex might confer 
resistance to ADAMTS proteolytic activity in this model. 
The neonatal murine epiphyseal chondrocyte model is a valu- 
able tool for investigating aggrecan synthesis and turnover by 
ADAMTS proteases, since aggrecanase activity is an inherent 
property of the model, and does not require stimulation by retinoic 
acid or inflammatory cytokines. The murine epiphyseal model 
provides an excellent system to investigate pathways that reg- 
ulate ADAMTS expression and activity through genetic manipu- 
lations of mouse strains and by pharmacological treatment of the 
culture model itself. 
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Aim of the Study: To evaluate the expression and function of 
Rev-ErbAa in cartilage and in osteoarthritis (OA). 
Methods: The expression of Rev-ErbAa in cartilage was ob- 
served at both RNA and protein level in cartilage and chon- 
drocytes derived from human and bovine donors by real time 
PCR and immunocytochemical techniques. The effect of carti- 
lage catabolic agents like ILl and TNF and anabolic agents such 
as IGF-1 and TGFb, on the expression of Rev-ErbAa was evalu- 
ated by real time PCR assay. The overexpression of Rev-ErbAa 
was achieved by either adenoviral transduction or treatment with 
a PPARa agonist whereas its expression was suppressed by use 
of antisense oligonucleotides. The effect of overexpression and 
suppression on the expression of genes encoding matrix degrad- 
ing enzymes and production of Aggrecanase was measured by 
real time PCR and a chondrocyte-based Aggrecanase assay, re- 
spectively. 
Results: An important feature of OA is the degradation of articu- 
lar cartilage which is composed of matrix rich in type II Collagen 
and Aggrecan. This process is likely related to the excess synthe- 
sis and release of several catabolic factors such as proinflamma- 
tory cytokines, MMPs and Aggrecanases. Thus, the modulation 
of these catabolic factors may lead to the identification of new 
therapeutic targets for the treatment of OA in humans. 
In a survey examining the expression of all 48 nuclear receptors, 
Rev-ErbAa, an orphan nuclear receptor, was found to be the most 
highly expressing nuclear receptor in chondrocytes. Unlike other 
liganded nuclear receptors Rev-ErbAa belongs to a subfamily of 
orphan receptors that are repressors of target gene transcription. 
Immunocytochemical ssay revealed a restricted but prominent 
expression of Rev-ErbAa in the midzone of articular cartilage ob- 
tained from human donors. Treatment of isolated articular chon- 
drocytes with known catabolic agents resulted in an induction of 
Rev-ErbAa, while stimulation with anabolic agents led to a de- 
crease in its expression. Increased expression of Rev-ErbAa was 
associated with an increase in levels of mRNA encoding ma- 
trix degrading enzymes such MMP13 and ADAMTS-4 whereas 
a decrease in Rev-ErbAa expression led to a concomitant reduc- 
tion in mRNA levels of matrix degrading enzymes and a corre- 
sponding decrease in IL-1-stimulated Aggrecanase enzyme pro- 
duction. 
Conclusion: This is the first report demonstrating a key role of 
Rev-ErbAa in both catabolic and anabolic processes in cartilage. 
These data also suggest that modulation of Rev-ErbAa may be 
a novel means to regulate the expression and production of ma- 
trix degrading enzymes and that it represents a novel therapeutic 
target for OA. 
